Ameriprise’s DermTech, Inc. Common Stock DMTK Stock Holding History

Ameriprise’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-616,035	Closed	-$9.73M	–	4044
2021 Q4	$9.73M	Buy	616,035 +33,824	+6%	+$812K	﹤0.01%	2002
2021 Q3	$18.7M	Buy	582,211 +1,113	+0.2%	+$39.1K	0.01%	1317
2021 Q2	$24.1M	Sell	581,098 -117,589	-17%	-$4.83M	0.01%	1212
2021 Q1	$35.3M	Sell	698,687 -88,298	-11%	-$4.62M	0.01%	948
2020 Q4	$25.5M	Buy	+786,985	New	+$11.2M	0.01%	1072

Other funds holding DMTK

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Ameriprise's DMTK Position: Q1 2022 in Review

Ameriprise sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2022, closing a stake of 616,035 shares — an estimated $9.73M sold.

Ameriprise first reported a position in DMTK in Q4 2020 and held it in 5 quarters. The position peaked at $35.3M in Q1 2021. 152 funds tracked by Wall St. Rank hold DMTK as of Q1 2022.

Ameriprise reported no remaining DermTech, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Ameriprise sold 616,035 DermTech, Inc. Common Stock shares in Q1 2022, an estimated $9.73M.
Ameriprise first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Ameriprise's DermTech, Inc. Common Stock position peaked at $35.3M in Q1 2021.
152 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2022.

Based on Ameriprise's 13F filing for Q1 2022, filed 16 May 2022.